Tag Archives: IASLC

#WCLC2018 conclusions – NELSON study shows CT Screening for Nodule Volume Management Reduces Lung Cancer Mortality by 26 Percent in Men

During the World Congress on Lung Cancer held this year in Toronto, Canada were presented the findings of NELSON study. These demonstrate that the use of computed tomography (CT) screening among asymptomatic men at high risk for lung cancer led to a 26 percent (9-41%, 95% CI) reduction in lung cancer deaths at 10 years of study follow-up (at 86% […]

Read More

IASLC issues statement paper on liquid biopsy for lung cancer

The lungs can be a difficult organ to biopsy with a needle, so the promise of identifying lung cancer through a blood-based biopsy has lung cancer experts and patients optimistic. Knowing how and when to use a liquid biopsy is critically important and led global experts at the International Association for the Study of Lung Cancer (IASLC) to issue “The […]

Read More

Presentation: Patient perspective on lung cancer treatment progress

Stefania, Vallone, LuCE President, was key note speaker @IASLC Lung Cancer Immunotherapy Meeting, held between March 22-25, 2018 in Barcelona. She was presenting patient perspective on lung cancer treatment progress, by providing useful insight information on patient helth literacy on immunotherapy. You can find the presentation here: https://bit.ly/2I1IExi

Read More